Management for R&D in Pharmaceutical Supply Chains

被引：0
|
作者：
Huang Yin [1 ]
Li Xiamiao [1 ]
Liu Dapeng [1 ]
机构：
[1] Cent S Univ, Sch Transportat & Traff Engn, Changsha, Hunan, Peoples R China
来源：
MOT2009: PROCEEDINGS OF ZHENGZHOU CONFERENCE ON MANAGEMENT OF TECHNOLOGY, VOLS I AND II | 2009年
关键词：
Supply chains; pharmaceutical industries; management; REAL OPTIONS; MODELING FRAMEWORK; RISK-MANAGEMENT; OPTIMIZATION; UNCERTAINTY; PORTFOLIOS; PLANTS;
D O I：
暂无
中图分类号：
TP [自动化技术、计算机技术];
学科分类号：
0812 ;
摘要：
Over the last few years, management for R&D in pharmaceutical supply chain. Pharmaceutical products differ somewhat from other products. For this reason, a great deal of the recent research has focused on the research and development(R&D) projects. This article reviews the current literature on supply chain management for pharmaceutical products. The review discusses some interesting open research questions in this field, and points out new directions for future research.
引用
收藏
页码：638 / 644
页数：7
相关论文
共 50 条
  • [21] The changing shape of pharmaceutical R&D
    Nicolaides, D
    CHEMICAL INNOVATION, 2001, 31 (11): : 40 - 46
  • [22] R&D in the Global Pharmaceutical Markets
    Kermani, Faiz
    Wollowitz, Susan
    FUTURE OF THE CHEMICAL INDUSTRY, 2009, 1026 : 19 - 45
  • [23] MANAGING RISK IN PHARMACEUTICAL R&D
    Case, Randolph H.
    RESEARCH-TECHNOLOGY MANAGEMENT, 2010, 53 (02) : 24 - 32
  • [24] The productivity crisis in pharmaceutical R&D
    Fabio Pammolli
    Laura Magazzini
    Massimo Riccaboni
    Nature Reviews Drug Discovery, 2011, 10 : 428 - 438
  • [25] The Effect of Price on Pharmaceutical R&D
    Civan, Abdulkadir
    Maloney, Michael T.
    B E JOURNAL OF ECONOMIC ANALYSIS & POLICY, 2009, 9 (01):
  • [26] R&D portfolios and pharmaceutical licensing
    Nishimura, Junichi
    Okada, Yosuke
    RESEARCH POLICY, 2014, 43 (07) : 1250 - 1263
  • [27] Pharmaceutical R&D goes East
    Floether, Frank U.
    CHIMICA OGGI-CHEMISTRY TODAY, 2011, 29 (04) : 16 - 18
  • [28] The productivity crisis in pharmaceutical R&D
    Pammolli, Fabio
    Magazzini, Laura
    Riccaboni, Massimo
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 428 - 438
  • [29] Systems biology in pharmaceutical R&D
    Oresic, Matej
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S23 - S23
  • [30] The limits to upgrading and value capture in R&D global value chains: Indian and Chinese contract R&D firms in the integrated circuit design and pharmaceutical global value chains
    Fuller, Douglas B.
    Ramirez, Paulina
    COMPETITION & CHANGE, 2024, 28 (01) : 144 - 164
12345